Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017 (2017), Article ID 5746031, 5 pages
https://doi.org/10.1155/2017/5746031
Research Article

Chitinase-3-Like Protein 1 (YKL-40) Reflects the Severity of Symptoms in Atopic Dermatitis

Department of Dermatology, Venereology and Allergology, Wrocław Medical University, Wrocław, Poland

Correspondence should be addressed to Jacek C Szepietowski

Received 14 February 2017; Revised 14 April 2017; Accepted 16 May 2017; Published 4 June 2017

Academic Editor: Mahboobeh Mahdavinia

Copyright © 2017 Joanna Salomon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Werfel, J. P. Allam, T. Biedermann et al., “Cellular and molecular immunologic mechanisms in patients with atopic dermatitis,” The Journal of Allergy and Clinical Immunology, vol. 138, pp. 336–349, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Salimi, J. L. Barlow, S. P. Saunders et al., “A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis,” The Journal of Experimental Medicine, vol. 210, pp. 2939–2950, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Skabytska, S. Kaesler, T. Volz, and T. Biedermann, “The role of innate immune signalling in the pathogenesis of atopic dermatitis and consequences for treatments,” Seminars in Immunopathology, vol. 38, pp. 29–43, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. L. M. Roesner, A. Heratizadeh, G. Begemann et al., “Der p1 and Der p2-specific T cells display a Th2, Th17, and Th2/Th17 phenotype in atopic dermatitis,” The Journal of Investigative Dermatology, vol. 135, no. 9, pp. 2324–2327, 2015. View at Google Scholar
  5. E. Wambre, J. H. DeLong, E. A. James, R. E. LaFond, D. Robinson, and W. W. Kwok, “Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy,” The Journal of Allergy and Clinical Immunology, vol. 129, pp. 544–551, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Wambre, D. L. JH, E. A. James et al., “Specific immunotherapy modifies allergen-specific CD4(+) T-cell response in an epitope-dependent manner,” The Journal of Allergy and Clinical Immunology, vol. 133, pp. 872–879, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. A. P. Bussink, D. Speijer, J. M. Aerts, and R. G. Boot, “Evolution of mammalian chitinase(-like) members of family 18 glycosyl hydrolases,” Genetics, vol. 177, pp. 959–970, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. C. G. Lee, C. A. Da Silva, C. S. Dela Cruz et al., “Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodelling and injury,” Annual Review of Physiology, vol. 73, pp. 479–501, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. J. S. Johansen, B. V. Jensen, A. Roslind, D. Nielsen, and P. A. Price, “Serum YKL-40, a new prognostic biomarker in cancer patients?” Cancer Epidemiology, Biomarkers & Prevention, vol. 15, pp. 194–202, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Volck, J. S. Johansen, M. Stoltenberg et al., “Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology,” Osteoarthritis and Cartilage, vol. 9, pp. 203–214, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Prakash, M. Bodas, D. Prakash et al., “Diverse pathological implications of YKL-40: answers may lie in ‘outside-in’ signalling,” Cellular Signalling, vol. 25, pp. 1567–1573, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Erzin, H. Uzun, A. Karatas, and A. F. Celik, “Serum YKL-40 as a marker of disease activity and structure formation in patients with Crohn’s disease,” Journal of Gastroenterology and Hepatology, vol. 23, pp. e357–e362, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. C. G. Lee, D. Hartl, G. R. Lee et al., “Role of breast regression protein 39 (BRP-39)/chitinase 3 like-1 in th2 and IL-13-induced tissue responses and apoptosis,” The Journal of Experimental Medicine, vol. 206, pp. 1149–1166, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. C. G. Lee, “Chitin, chitinases and chitinase-like proteins in allergic inflammation and tissue remodelling,” Yonsei Medical Journal, vol. 50, pp. 22–30, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. C. G. Lee and J. A. Elias, “Role of breast regression protein-39/YKL-40 in asthma and allergic responses,” Allergy Asthma Immunology Research, vol. 2, pp. 20–27, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. M. H. Sohn, J. H. Lee, K. W. Kim et al., “Genetic variation in the promoter region of chitinase 3-like 1 is associated with atopy,” American Journal of Respiratory and Critical Care Medicine, vol. 179, pp. 449–456, 2009. View at Google Scholar
  17. D. E. Komi, T. Kazemi, and A. P. Bussink, “New insights into the relationship between chitinase-3-like-1 and asthma,” Current Allergy and Asthma Reports, vol. 16, p. 57, 2016. View at Google Scholar
  18. J. H. Lee, K. H. Park, J. W. Park, and C. S. Hong, “YKL-40 in induced sputum after allergen bronchial provocation in atopic asthma,” Journal of Investigational Allergology & Clinical Immunology, vol. 22, pp. 501–507, 2012. View at Google Scholar
  19. S. J. Park, Y. J. Jun, T. H. Kim et al., “Increased expression of YKL-40 in mild and moderate/severe persistent allergic rhinitis and its possible contribution to remodelling of nasal mucosa,” American Journal of Rhinology & Allergy, vol. 27, pp. 372–380, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. J. M. Hanifin and G. Rajka, “Diagnostic features of atopic dermatitis,” Acta Dermatology Venereol, vol. 92, Supplement, pp. 44–47, 1980. View at Google Scholar
  21. “Severity scoring of atopic dermatitis: the SCORAD Index. Consensus report of the European Task Force on Atopic Dermatitis,” Dermatology, vol. 186, pp. 23–31, 1993.
  22. C. Ober, Z. Tan, Y. Sun et al., “Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function,” The New England Journal of Medicine, vol. 358, pp. 1682–1691, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. C. N. Rathcke, J. Holmkvist, L. L. N. Husmoen et al., “Association of polymorphisms of the CHI3L1 gene with asthma and atopy: a population-based study of 6514 Danish adults,” PloS One, vol. 4, no. 7, article e6106, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. G. L. Chupp, C. G. Lee, N. Jarjour et al., “A chitinase-like protein in the lung and circulation of patients with severe asthma,” The New England Journal of Medicine, vol. 357, pp. 2016–2027, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. A. J. James, L. E. Reinius, M. Verhoek et al., “BIOAIR (longitudinal assessment of clinical course and biomarkers in severe chronic airway disease) consortium. Increased YKL-40 and chitotriosidase in asthma and chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 193, pp. 131–142, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Saba, M. R. Sharif, H. Akbari, H. Nikoueinejad, and J. M. Ramazani, “YKL-40 in asthma and its correlation with different clinical parameters,” Iranian Journal of Allergy, Asthma, and Immunology, vol. 13, pp. 271–277, 2014. View at Google Scholar
  27. K. Specjalski, M. Chełmińska, and E. Jassem, “YKL-40 protein correlates with the phenotype of asthma,” Lung, vol. 193, pp. 189–194, 2015. View at Publisher · View at Google Scholar · View at Scopus